Quality Systems, Clinical Development & Regulatory Intelligence; building credibility, scalability and longevity in the Medicinal Cannabis Sector

When it comes to cannabis, regulation is not a barrier, but rather a business builder.

In this insightful episode, Jaydon Inott, an industry expert in GMP, regulatory systems, clinical development, and licensing strategy, speaks with Christopher Tasker (BSc, MRes) from Global Cannabinoid Solutions about how we can drive sustainable success in the cannabis sector.

Together, they explore:

• How established frameworks for clinical development and product licensing provide more certainty and open up future growth for the sector

• How regulatory frameworks offer market stability

• Why GMP and quality systems build global credibility

• The importance of forward thinking licensing strategies for scaling cannabis operations

Rather than being an obstacle, compliance is shown to be a strategic asset that opens doors to new markets, strengthens investor confidence and lays the groundwork for clinical excellence.

Watch the full discussion here:

https://www.cannabissciencetraining.com/p/l/eyJhbGciOiJIUzI1NiJ9.eyJuZXdzbGV0dGVyX2xpbmtfaWQiOjMxNTk1Mzh9.9xQ2_A3Dh2A4JUBjNHA6ABO-xO7jYnF8THYCln0yo1o/eyJhbGciOiJIUzI1NiJ9.eyJzdHVkZW50X2lkIjoyMjkwNDQxNCwibmV3c2xldHRlcl9pZCI6MjUyMjgxOX0.Da_r8-kw3cYWmRrHj4vcaJdy5Ev08kPaRxHCASCbCec